The Vienna-based pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health), which specializes in rare diseases and critical care medicine, is repositioning itself strategically. In order to offer patients and healthcare professionals state-of-the-art therapy concepts not only today, but also in the future, AOP Health is introducing new structures to achieve more efficient operations and growth.
Roland Bindeus (45 years old), who has been promoted to Senior Director Commercial at the headquarters in Vienna, is responsible for this strategic development. Born in Austria, he studied biochemistry at the University of Vienna and has over 15 years of experience in national and international positions in the pharmaceutical industry. He has been with AOP Health since 2016, most recently serving as Director for the German-speaking countries.
In his new role, Bindeus will oversee the four therapy areas of Hemato-Oncology, Cardiology and Pulmonology, Critical Care Medicine, and Neurology and Metabolic Disorders. With the introduction of Commercial Excellence, he will establish a new unit focusing on business data analysis, digital applications, global congress and conference management, and the coordination of standards and training. Roland Bindeus will report to Petra Lanz, Chief Commercial Officer at AOP Health.
Source: AOP Health